Atopic Dermatitis in Older Adults: Common, Unique, and Challenging to Manage

Dermatitis News

Atopic Dermatitis in Older Adults: Common, Unique, and Challenging to Manage
GeriatricsElder CareGeriatric Medicine
  • 📰 Medscape
  • ⏱ Reading Time:
  • 68 sec. here
  • 34 min. at publisher
  • 📊 Quality Score:
  • News: 138%
  • Publisher: 55%

The research on atopic dermatitis demonstrates that 'the age of onset is distributed well throughout the lifespan,' said Jonathan Silverberg, MD, PhD, MPH.

WASHINGTON, DC — The onset of atopic dermatitis in older adulthood — even in adults aged ≥ 90 years — is a phenomenon documented in the literature in recent years, with reports showing age-related immune differences and differences in risk factors,, MD, PhD, MPH, said at the ElderDerm Conference on dermatology in the older patient hosted by the George Washington University School of Medicine and Health Sciences, Washington, DC.

"The peak usage for dermatologists, primary care physicians, etc., is happening in the first few years of life, partially because that's when the disease is more common and more severe but also partially because that's when parents and caregivers are first learning the disease and trying to understand how to gain control," Silverberg said at the meeting, presenting data from an expanded, unpublished analysis of NAMCS data showing these same outpatient utilization patterns.

Adults aged > 60 years showed more lesions on the trunk and extensor sites of the extremities and lower levels of serum IgE and peripheral eosinophil counts than those in younger age groups. And"interestingly," compared with healthy controls, older patients with AD had"higher levels of serum expression of a variety of cytokines, including IL -4 but also high TARC levels…and a variety of cytokines related to the Th17, TH1 axes, etc.," he said.

"The aging population has dysregulated sleep patterns and altered circadian rhythms, so some of this is just natural predisposition," Silverberg said."But it's amplified , and it becomes a big clinical problem when we get into treatment because it's our natural inclination to prescribe antihistamines for their sedative properties."

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Medscape /  🏆 386. in US

Geriatrics Elder Care Geriatric Medicine Older Adults Seniors Senior Citizens Elderly Toxicology Toxicity Poisoning Toxins Elderly/Concerns Of Older Adults Elderly Atopic Dermatitis Atopic Eczema Children Child Childhood Pediatrics Kids Genomics Genomic Medicine Genetics Environmental Exposure Pollutant Pollution Sleep Asthma Asthmatic Ige Immunoglobulin E

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Does Dupilumab Affect Atopic March Progression in Children With Atopic Dermatitis?Does Dupilumab Affect Atopic March Progression in Children With Atopic Dermatitis?Dupilumab therapy was more effective than conventional treatments in reducing the risk of developing allergic rhinitis or asthma in children with atopic dermatitis.
Read more »

Study Eyes MACE Risk in Moderate to Severe Atopic DermatitisStudy Eyes MACE Risk in Moderate to Severe Atopic DermatitisThe findings contrast with the expectation that increased systemic inflammation in moderate to severe AD would correspond with a higher incidence of MACE, said Bunick.
Read more »

Survey Spotlights Real-World Experience With Upadacitinib for Atopic DermatitisSurvey Spotlights Real-World Experience With Upadacitinib for Atopic DermatitisAbout 28% of respondents reported itch improvement within 1 day of taking the drug.
Read more »

Review Finds Dupilumab Benefits Kids With Atopic Dermatitis and AlopeciaReview Finds Dupilumab Benefits Kids With Atopic Dermatitis and AlopeciaDupilumab treatment was associated with improved hair growth and reduced severity of atopic dermatitis in a review.
Read more »

Dupilumab Safe, Effective Over 5 Years in Moderate to Severe Atopic DermatitisDupilumab Safe, Effective Over 5 Years in Moderate to Severe Atopic DermatitisLong-term data confirm safety and efficacy of dupilumab treatment, which offered sustained efficacy without any new safety incidents in patients with moderate to severe AD.
Read more »

Age in America: Older adults utilizing technology to make workouts 'easy'Age in America: Older adults utilizing technology to make workouts 'easy'Rooted in fact-based, transparent reporting, Newsy is an award-winning opinion-free network owned by the E.W. Scripps Company that is relentlessly focused on “the why” of every story and seeks to enable a more intimate and immersive understanding of the issues that matter.
Read more »



Render Time: 2025-02-13 10:01:15